Cardiopar
Cardiopar is an FDA drug label for the active ingredient CONVALLARIA MAJALIS, APOCYNUM CANNABINUM, ARTERIA SUIS, HEART (SUIS), THYROIDINUM (SUIS), ADONIS VERNALIS, CACTUS GRANDIFLORUS, DIGITALIS PURPUREA, LYCOPUS VIRGINICUS manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230608.
Generic: CONVALLARIA MAJALIS, APOCYNUM CANNABINUM, ARTERIA SUIS, HEART (SUIS), THYROIDINUM (SUIS), ADONIS VERNALIS, CACTUS GRANDIFLORUS, DIGITALIS PURPUREA, LYCOPUS VIRGINICUS
Manufacturer: Energique, Inc.
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 44911-0532
Application:
Effective: 20230608
Active Ingredients: ACTIVE INGREDIENTS: (in each drop): 12.49% of Adonis Vernalis 10X, Arteria Suis 8X, Cactus Grandiflorus 12X, Convallaria Majalis 4X, Digitalis Purpurea 12X, Heart (Suis) 8X, Lycopus Virginicus 12X, Thyroidinum (Suis) 8X; 0.10% of Apocynum Cannabinum 6X.
Indications & Usage
INDICATIONS: May temporarily relieve difficulty breathing after walking, tiredness, feeling as if you can't breathe, and profuse perspiration.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS: Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.
Contraindications
Not available.
Warnings
WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Adverse Reactions
Not available.
More from same ingredient
No related products.